Epilepsy Prevalence and Intervention Study in Zhejiang Province, China

NCT ID: NCT04944641

Last Updated: 2021-07-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-13

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To carry out the epidemiological investigation on epilepsy in Zhejiang Province, China, and then establish early comprehensive intervention to help patients with epilepsy to improve seizure control and the quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To carry out the epidemiological investigation on epilepsy in Zhejiang Province, China, and then establish early comprehensive intervention(proper antiepileptic drugs and education intervention) to help patients with epilepsy to improve seizure control and the quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epilepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomly group into two
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A: Routine AED group

Routine and proper antiepileptic drugs group

Group Type EXPERIMENTAL

routine and proper antiepileptic drugs

Intervention Type DRUG

routine and proper antiepileptic drugs

B: AED and education group

Routine, proper antiepileptic drugs and education group

Group Type EXPERIMENTAL

education on epilepsy

Intervention Type BEHAVIORAL

education on epilepsy, including epilepsy diary, pamphlet,discussion between patients and phone visits and so on

routine and proper antiepileptic drugs

Intervention Type DRUG

routine and proper antiepileptic drugs

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

education on epilepsy

education on epilepsy, including epilepsy diary, pamphlet,discussion between patients and phone visits and so on

Intervention Type BEHAVIORAL

routine and proper antiepileptic drugs

routine and proper antiepileptic drugs

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Newly diagnosed and untreated epilepsy; Aged 14 and above; Sign the informed consents.

Exclusion Criteria

With intellectual development disorder; With serious heart and lung diseases.
Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hangzhou Center of Disease Control and Prevention

OTHER_GOV

Sponsor Role collaborator

The Central Hospital of Lishui City

OTHER

Sponsor Role collaborator

The Second Affiliated Hospital of Jiaxing University

OTHER

Sponsor Role collaborator

Zhejiang University

OTHER

Sponsor Role collaborator

Children's Hospital Affiliated to Zhejiang University School of Medicine

UNKNOWN

Sponsor Role collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Hangzhou, Zhejiang, China

Site Status RECRUITING

Shengzhou People's Hospital

Shengzhou, , China

Site Status COMPLETED

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mei-ping Ding

Role: CONTACT

13588058581

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mei-ping Ding

Role: primary

13588058581

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-032

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.